Factors Associated with Rivaroxaban Prescribing in Specialist Care Setting: Interim Results from the Rivaroxaban Observational Safety Evaluation (ROSE) Study

被引：0
|
作者：
Layton, Deborah [1 ,2 ]
Evans, Alison [1 ,2 ]
Davies, Miranda [1 ,2 ]
Osborne, Vicki [1 ,2 ]
Shakir, Saad A. W. [1 ,2 ]
机构：
[1] Drug Safety Res Unit, Southampton, Hants, England
[2] Univ Portsmoth, Portsmouth, Hants, England
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2016年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
337
引用
收藏
页码：197 / 198
页数：2
相关论文
共 50 条
  • [21] Using primary care data to assess comparative effectiveness and safety of apixaban and rivaroxaban in patients with nonvalvular atrial fibrillation in the UK: an observational cohort study
    Jaksa, Ashley
    Gibbs, Liza
    Kent, Seamus
    Rowark, Shaun
    Duffield, Stephen
    Sharma, Manuj
    Kincaid, Lynne
    Ali, Ayad K.
    Patrick, Amanda R.
    Govil, Priya
    Jonsson, Pall
    Gatto, Nicolle
    BMJ OPEN, 2022, 12 (10):
  • [22] Safety of the Hexavalent Vaccine as Used in General Practice: Interim Results from a Prospective Observational Study
    Bulik, N. Beatrix
    Bucsa, C.
    Farcas, A.
    Oniga, O.
    DRUG SAFETY, 2017, 40 (10) : 973 - 974
  • [23] Utilisation and safety of asenapine in secondary care in the United Kingdom: Results from the observational safety evaluation of asenapine (OBSERVA) study
    Dhanda, Sandeep
    Slade, Jan
    Osborne, Vicki
    Wise, Lesley
    Shakir, Saad
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 272 - 273
  • [24] Efficacy and Safety of Different Doses of Rivaroxaban and Risk Factors for Bleeding in Elderly Patients with Venous Thromboembolism: A Real-World, Multicenter, Observational, Cohort Study
    Lu, Kepeng
    Liao, Qian-Qian
    Zhu, Ke-Wei
    Yao, Ying
    Cui, Xiao-Jiao
    Chen, Peng
    Bi, Ying
    Zhong, Meng
    Zhang, Hao
    Tang, Jing-Cai
    Yu, Qin
    Yue, Jia-Kui
    He, Hui
    Zhu, Ze-Feng
    Cai, Ze-Zheng
    Yang, Zhe
    Zhang, Wei
    Dong, Yang-Tao
    Wei, Qiu-Mian
    He, Xuegai
    ADVANCES IN THERAPY, 2024, 41 (01) : 391 - 412
  • [25] Efficacy and Safety of Different Doses of Rivaroxaban and Risk Factors for Bleeding in Elderly Patients with Venous Thromboembolism: A Real-World, Multicenter, Observational, Cohort Study
    Kepeng Lu
    Qian-Qian Liao
    Ke-Wei Zhu
    Ying Yao
    Xiao-Jiao Cui
    Peng Chen
    Ying Bi
    Meng Zhong
    Hao Zhang
    Jing-Cai Tang
    Qin Yu
    Jia-Kui Yue
    Hui He
    Ze-Feng Zhu
    Ze-Zheng Cai
    Zhe Yang
    Wei Zhang
    Yang-Tao Dong
    Qiu-Mian Wei
    Xuegai He
    Advances in Therapy, 2024, 41 : 391 - 412
  • [26] Safety and effectiveness of insulin detemir in combination with oral antidiabetic agents in an outpatient specialist setting: results of the Italian SOLVE™ observational study
    Caputo, S.
    Maran, A.
    Mannino, D.
    Morano, S.
    Lastoria, G.
    Nicoziani, P.
    MINERVA ENDOCRINOLOGICA, 2015, 40 (04) : 249 - 258
  • [27] Evaluation of the incidence of bleeding in patients prescribed rivaroxaban for the treatment and prevention of deep vein thrombosis and pulmonary embolism in UK secondary care: an observational cohort study
    Evans, Alison
    Davies, Miranda
    Osborne, Vicki
    Roy, Debabrata
    Shakir, Saad
    BMJ OPEN, 2020, 10 (11):
  • [28] Utilization of dulaglutide in primary Care in England: Interim results from a post authorisation safety study
    Davies, Miranda
    Hazell, Lorna
    Dhanda, Sandeep
    Osborne, Vicki
    Ali, Ayad K.
    Shakir, Saad
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 514 - 514
  • [29] Patterns of Tocilizumab Use and Safety in Patients with Rheumatoid Arthritis: Interim Results from a Multinational Observational Study.
    Haraoui, Boulos
    Casado, Gustavo
    Theander, Elke
    Czirjak, Laszlo
    Taylor, Andrew
    Button, Peter
    Gylvin, Lykke Hinsch
    Caporali, Roberto
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S226 - S226
  • [30] Major bleeding among patients with atrial fibrillation treated with rivaroxaban or warfarin in Sweden. Interim results from an on-going post-authorization study
    Friberg, L.
    EUROPEAN HEART JOURNAL, 2016, 37 : 402 - 403
12345